BOLT vs FOX · rev $7.7M vs P/E 13, rev $16.30B
Bolt Biotherapeutics (BOLT) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
BOLT currently screens at market cap $11.3M. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the BOLT and FOX stock pages for the full models.
Not investment advice.